Global Normothermic Perfusion of Isolated Organs Market Growth (Status and Outlook) 2026-2032

July 2026 | 116 pages | ID: G138629BAF2AEN
LP Information

Abstracts

The global Normothermic Perfusion of Isolated Organs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

This report presents a comprehensive overview, market shares, and growth opportunities of Normothermic Perfusion of Isolated Organs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Heart Perfusion
• Liver Perfusion
• Kidney Perfusion
• Lung Perfusion

Segmentation by Application:

• Organ Transplant Specialist Hospitals
• Organ Banks
• Pharmaceutical Research Organizations

This report also splits the market by region:

• United States
• China%li%
• Europe
• Other regions
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• TransMedics
• Lung Bioengineering
• OrganOx
• XVIVO
• TNO
• UHN
• SCREEN
• Bridge to Life
• Organ Recovery Systems
• Institut Georges Lopez
• Ebers
• Penn Medicine
• Johns Hopkins Medicine

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Normothermic Perfusion of Isolated Organs Market Size (2021-2032)
  2.1.2 Normothermic Perfusion of Isolated Organs Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Normothermic Perfusion of Isolated Organs by Country/Region (2021, 2025 & 2032)
2.2 Normothermic Perfusion of Isolated Organs Segment by Type
  2.2.1 Heart Perfusion
  2.2.2 Liver Perfusion
  2.2.3 Kidney Perfusion
  2.2.4 Lung Perfusion
  2.2.5 Normothermic Perfusion of Isolated Organs Market Size by Type
    2.2.5.1 Normothermic Perfusion of Isolated Organs Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.5.2 Global Normothermic Perfusion of Isolated Organs Market Size Market Share by Type (2021-2026)
2.3 Normothermic Perfusion of Isolated Organs Segment by Application
  2.3.1 Organ Transplant Specialist Hospitals
  2.3.2 Organ Banks
  2.3.3 Pharmaceutical Research Organizations
  2.3.4 Normothermic Perfusion of Isolated Organs Market Size by Application
    2.3.4.1 Normothermic Perfusion of Isolated Organs Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Normothermic Perfusion of Isolated Organs Market Size Market Share by Application (2021-2026)

3 NORMOTHERMIC PERFUSION OF ISOLATED ORGANS MARKET SIZE BY PLAYER

3.1 Normothermic Perfusion of Isolated Organs Market Size Market Share by Player
  3.1.1 Global Normothermic Perfusion of Isolated Organs Revenue by Player (2021-2026)
  3.1.2 Global Normothermic Perfusion of Isolated Organs Revenue Market Share by Player (2021-2026)
3.2 Global Normothermic Perfusion of Isolated Organs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NORMOTHERMIC PERFUSION OF ISOLATED ORGANS BY REGION

4.1 Normothermic Perfusion of Isolated Organs Market Size by Region (2021-2026)
4.2 Global Normothermic Perfusion of Isolated Organs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Normothermic Perfusion of Isolated Organs Market Size Growth (2021-2026)
4.4 APAC Normothermic Perfusion of Isolated Organs Market Size Growth (2021-2026)
4.5 Europe Normothermic Perfusion of Isolated Organs Market Size Growth (2021-2026)
4.6 Middle East & Africa Normothermic Perfusion of Isolated Organs Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Normothermic Perfusion of Isolated Organs Market Size by Country (2021-2026)
5.2 Americas Normothermic Perfusion of Isolated Organs Market Size by Type (2021-2026)
5.3 Americas Normothermic Perfusion of Isolated Organs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Normothermic Perfusion of Isolated Organs Market Size by Region (2021-2026)
6.2 APAC Normothermic Perfusion of Isolated Organs Market Size by Type (2021-2026)
6.3 APAC Normothermic Perfusion of Isolated Organs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Normothermic Perfusion of Isolated Organs Market Size by Country (2021-2026)
7.2 Europe Normothermic Perfusion of Isolated Organs Market Size by Type (2021-2026)
7.3 Europe Normothermic Perfusion of Isolated Organs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Normothermic Perfusion of Isolated Organs by Region (2021-2026)
8.2 Middle East & Africa Normothermic Perfusion of Isolated Organs Market Size by Type (2021-2026)
8.3 Middle East & Africa Normothermic Perfusion of Isolated Organs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NORMOTHERMIC PERFUSION OF ISOLATED ORGANS MARKET FORECAST

10.1 Global Normothermic Perfusion of Isolated Organs Forecast by Region (2027-2032)
  10.1.1 Global Normothermic Perfusion of Isolated Organs Forecast by Region (2027-2032)
  10.1.2 Americas Normothermic Perfusion of Isolated Organs Forecast
  10.1.3 APAC Normothermic Perfusion of Isolated Organs Forecast
  10.1.4 Europe Normothermic Perfusion of Isolated Organs Forecast
  10.1.5 Middle East & Africa Normothermic Perfusion of Isolated Organs Forecast
10.2 Americas Normothermic Perfusion of Isolated Organs Forecast by Country (2027-2032)
  10.2.1 United States Market Normothermic Perfusion of Isolated Organs Forecast
  10.2.2 Canada Market Normothermic Perfusion of Isolated Organs Forecast
  10.2.3 Mexico Market Normothermic Perfusion of Isolated Organs Forecast
  10.2.4 Brazil Market Normothermic Perfusion of Isolated Organs Forecast
10.3 APAC Normothermic Perfusion of Isolated Organs Forecast by Region (2027-2032)
  10.3.1 China Normothermic Perfusion of Isolated Organs Market Forecast
  10.3.2 Japan Market Normothermic Perfusion of Isolated Organs Forecast
  10.3.3 Korea Market Normothermic Perfusion of Isolated Organs Forecast
  10.3.4 Southeast Asia Market Normothermic Perfusion of Isolated Organs Forecast
  10.3.5 India Market Normothermic Perfusion of Isolated Organs Forecast
  10.3.6 Australia Market Normothermic Perfusion of Isolated Organs Forecast
10.4 Europe Normothermic Perfusion of Isolated Organs Forecast by Country (2027-2032)
  10.4.1 Germany Market Normothermic Perfusion of Isolated Organs Forecast
  10.4.2 France Market Normothermic Perfusion of Isolated Organs Forecast
  10.4.3 UK Market Normothermic Perfusion of Isolated Organs Forecast
  10.4.4 Italy Market Normothermic Perfusion of Isolated Organs Forecast
  10.4.5 Russia Market Normothermic Perfusion of Isolated Organs Forecast
10.5 Middle East & Africa Normothermic Perfusion of Isolated Organs Forecast by Region (2027-2032)
  10.5.1 Egypt Market Normothermic Perfusion of Isolated Organs Forecast
  10.5.2 South Africa Market Normothermic Perfusion of Isolated Organs Forecast
  10.5.3 Israel Market Normothermic Perfusion of Isolated Organs Forecast
  10.5.4 Turkey Market Normothermic Perfusion of Isolated Organs Forecast
10.6 Global Normothermic Perfusion of Isolated Organs Forecast by Type (2027-2032)
10.7 Global Normothermic Perfusion of Isolated Organs Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Normothermic Perfusion of Isolated Organs Forecast

11 KEY PLAYERS ANALYSIS

11.1 TransMedics
  11.1.1 TransMedics Company Information
  11.1.2 TransMedics Normothermic Perfusion of Isolated Organs Product Offered
  11.1.3 TransMedics Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 TransMedics Main Business Overview
  11.1.5 TransMedics Latest Developments
11.2 Lung Bioengineering
  11.2.1 Lung Bioengineering Company Information
  11.2.2 Lung Bioengineering Normothermic Perfusion of Isolated Organs Product Offered
  11.2.3 Lung Bioengineering Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Lung Bioengineering Main Business Overview
  11.2.5 Lung Bioengineering Latest Developments
11.3 OrganOx
  11.3.1 OrganOx Company Information
  11.3.2 OrganOx Normothermic Perfusion of Isolated Organs Product Offered
  11.3.3 OrganOx Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 OrganOx Main Business Overview
  11.3.5 OrganOx Latest Developments
11.4 XVIVO
  11.4.1 XVIVO Company Information
  11.4.2 XVIVO Normothermic Perfusion of Isolated Organs Product Offered
  11.4.3 XVIVO Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 XVIVO Main Business Overview
  11.4.5 XVIVO Latest Developments
11.5 TNO
  11.5.1 TNO Company Information
  11.5.2 TNO Normothermic Perfusion of Isolated Organs Product Offered
  11.5.3 TNO Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 TNO Main Business Overview
  11.5.5 TNO Latest Developments
11.6 UHN
  11.6.1 UHN Company Information
  11.6.2 UHN Normothermic Perfusion of Isolated Organs Product Offered
  11.6.3 UHN Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 UHN Main Business Overview
  11.6.5 UHN Latest Developments
11.7 SCREEN
  11.7.1 SCREEN Company Information
  11.7.2 SCREEN Normothermic Perfusion of Isolated Organs Product Offered
  11.7.3 SCREEN Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 SCREEN Main Business Overview
  11.7.5 SCREEN Latest Developments
11.8 Bridge to Life
  11.8.1 Bridge to Life Company Information
  11.8.2 Bridge to Life Normothermic Perfusion of Isolated Organs Product Offered
  11.8.3 Bridge to Life Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Bridge to Life Main Business Overview
  11.8.5 Bridge to Life Latest Developments
11.9 Organ Recovery Systems
  11.9.1 Organ Recovery Systems Company Information
  11.9.2 Organ Recovery Systems Normothermic Perfusion of Isolated Organs Product Offered
  11.9.3 Organ Recovery Systems Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Organ Recovery Systems Main Business Overview
  11.9.5 Organ Recovery Systems Latest Developments
11.10 Institut Georges Lopez
  11.10.1 Institut Georges Lopez Company Information
  11.10.2 Institut Georges Lopez Normothermic Perfusion of Isolated Organs Product Offered
  11.10.3 Institut Georges Lopez Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Institut Georges Lopez Main Business Overview
  11.10.5 Institut Georges Lopez Latest Developments
11.11 Ebers
  11.11.1 Ebers Company Information
  11.11.2 Ebers Normothermic Perfusion of Isolated Organs Product Offered
  11.11.3 Ebers Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Ebers Main Business Overview
  11.11.5 Ebers Latest Developments
11.12 Penn Medicine
  11.12.1 Penn Medicine Company Information
  11.12.2 Penn Medicine Normothermic Perfusion of Isolated Organs Product Offered
  11.12.3 Penn Medicine Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 Penn Medicine Main Business Overview
  11.12.5 Penn Medicine Latest Developments
11.13 Johns Hopkins Medicine
  11.13.1 Johns Hopkins Medicine Company Information
  11.13.2 Johns Hopkins Medicine Normothermic Perfusion of Isolated Organs Product Offered
  11.13.3 Johns Hopkins Medicine Normothermic Perfusion of Isolated Organs Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 Johns Hopkins Medicine Main Business Overview
  11.13.5 Johns Hopkins Medicine Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Normothermic Perfusion of Isolated Organs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Normothermic Perfusion of Isolated Organs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Heart Perfusion
Table 4. Major Players of Liver Perfusion
Table 5. Major Players of Kidney Perfusion
Table 6. Major Players of Lung Perfusion
Table 7. Normothermic Perfusion of Isolated Organs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Normothermic Perfusion of Isolated Organs Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Normothermic Perfusion of Isolated Organs Market Size Market Share by Type (2021-2026)
Table 10. Normothermic Perfusion of Isolated Organs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Normothermic Perfusion of Isolated Organs Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Normothermic Perfusion of Isolated Organs Market Size Market Share by Application (2021-2026)
Table 13. Global Normothermic Perfusion of Isolated Organs Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Normothermic Perfusion of Isolated Organs Revenue Market Share by Player (2021-2026)
Table 15. Normothermic Perfusion of Isolated Organs Key Players Head office and Products Offered
Table 16. Normothermic Perfusion of Isolated Organs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Normothermic Perfusion of Isolated Organs Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Normothermic Perfusion of Isolated Organs Market Size Market Share by Region (2021-2026)
Table 21. Global Normothermic Perfusion of Isolated Organs Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Normothermic Perfusion of Isolated Organs Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Normothermic Perfusion of Isolated Organs Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Normothermic Perfusion of Isolated Organs Market Size Market Share by Country (2021-2026)
Table 25. Americas Normothermic Perfusion of Isolated Organs Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Normothermic Perfusion of Isolated Organs Market Size Market Share by Type (2021-2026)
Table 27. Americas Normothermic Perfusion of Isolated Organs Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Normothermic Perfusion of Isolated Organs Market Size Market Share by Application (2021-2026)
Table 29. APAC Normothermic Perfusion of Isolated Organs Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Normothermic Perfusion of Isolated Organs Market Size Market Share by Region (2021-2026)
Table 31. APAC Normothermic Perfusion of Isolated Organs Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Normothermic Perfusion of Isolated Organs Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Normothermic Perfusion of Isolated Organs Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Normothermic Perfusion of Isolated Organs Market Size Market Share by Country (2021-2026)
Table 35. Europe Normothermic Perfusion of Isolated Organs Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Normothermic Perfusion of Isolated Organs Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Normothermic Perfusion of Isolated Organs Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Normothermic Perfusion of Isolated Organs Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Normothermic Perfusion of Isolated Organs Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Normothermic Perfusion of Isolated Organs
Table 41. Key Market Challenges & Risks of Normothermic Perfusion of Isolated Organs
Table 42. Key Industry Trends of Normothermic Perfusion of Isolated Organs
Table 43. Global Normothermic Perfusion of Isolated Organs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Normothermic Perfusion of Isolated Organs Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Normothermic Perfusion of Isolated Organs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Normothermic Perfusion of Isolated Organs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. TransMedics Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 48. TransMedics Normothermic Perfusion of Isolated Organs Product Offered
Table 49. TransMedics Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. TransMedics Main Business
Table 51. TransMedics Latest Developments
Table 52. Lung Bioengineering Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 53. Lung Bioengineering Normothermic Perfusion of Isolated Organs Product Offered
Table 54. Lung Bioengineering Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Lung Bioengineering Main Business
Table 56. Lung Bioengineering Latest Developments
Table 57. OrganOx Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 58. OrganOx Normothermic Perfusion of Isolated Organs Product Offered
Table 59. OrganOx Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. OrganOx Main Business
Table 61. OrganOx Latest Developments
Table 62. XVIVO Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 63. XVIVO Normothermic Perfusion of Isolated Organs Product Offered
Table 64. XVIVO Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. XVIVO Main Business
Table 66. XVIVO Latest Developments
Table 67. TNO Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 68. TNO Normothermic Perfusion of Isolated Organs Product Offered
Table 69. TNO Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. TNO Main Business
Table 71. TNO Latest Developments
Table 72. UHN Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 73. UHN Normothermic Perfusion of Isolated Organs Product Offered
Table 74. UHN Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. UHN Main Business
Table 76. UHN Latest Developments
Table 77. SCREEN Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 78. SCREEN Normothermic Perfusion of Isolated Organs Product Offered
Table 79. SCREEN Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. SCREEN Main Business
Table 81. SCREEN Latest Developments
Table 82. Bridge to Life Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 83. Bridge to Life Normothermic Perfusion of Isolated Organs Product Offered
Table 84. Bridge to Life Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Bridge to Life Main Business
Table 86. Bridge to Life Latest Developments
Table 87. Organ Recovery Systems Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 88. Organ Recovery Systems Normothermic Perfusion of Isolated Organs Product Offered
Table 89. Organ Recovery Systems Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Organ Recovery Systems Main Business
Table 91. Organ Recovery Systems Latest Developments
Table 92. Institut Georges Lopez Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 93. Institut Georges Lopez Normothermic Perfusion of Isolated Organs Product Offered
Table 94. Institut Georges Lopez Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Institut Georges Lopez Main Business
Table 96. Institut Georges Lopez Latest Developments
Table 97. Ebers Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 98. Ebers Normothermic Perfusion of Isolated Organs Product Offered
Table 99. Ebers Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Ebers Main Business
Table 101. Ebers Latest Developments
Table 102. Penn Medicine Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 103. Penn Medicine Normothermic Perfusion of Isolated Organs Product Offered
Table 104. Penn Medicine Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Penn Medicine Main Business
Table 106. Penn Medicine Latest Developments
Table 107. Johns Hopkins Medicine Details, Company Type, Normothermic Perfusion of Isolated Organs Area Served and Its Competitors
Table 108. Johns Hopkins Medicine Normothermic Perfusion of Isolated Organs Product Offered
Table 109. Johns Hopkins Medicine Normothermic Perfusion of Isolated Organs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Johns Hopkins Medicine Main Business
Table 111. Johns Hopkins Medicine Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Normothermic Perfusion of Isolated Organs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Normothermic Perfusion of Isolated Organs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Normothermic Perfusion of Isolated Organs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Normothermic Perfusion of Isolated Organs Sales Market Share by Country/Region (2025)
Figure 8. Normothermic Perfusion of Isolated Organs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Normothermic Perfusion of Isolated Organs Market Size Market Share by Type in 2025
Figure 10. Normothermic Perfusion of Isolated Organs in Organ Transplant Specialist Hospitals
Figure 11. Global Normothermic Perfusion of Isolated Organs Market: Organ Transplant Specialist Hospitals (2021-2026) & ($ millions)
Figure 12. Normothermic Perfusion of Isolated Organs in Organ Banks
Figure 13. Global Normothermic Perfusion of Isolated Organs Market: Organ Banks (2021-2026) & ($ millions)
Figure 14. Normothermic Perfusion of Isolated Organs in Pharmaceutical Research Organizations
Figure 15. Global Normothermic Perfusion of Isolated Organs Market: Pharmaceutical Research Organizations (2021-2026) & ($ millions)
Figure 16. Global Normothermic Perfusion of Isolated Organs Market Size Market Share by Application in 2025
Figure 17. Global Normothermic Perfusion of Isolated Organs Revenue Market Share by Player in 2025
Figure 18. Global Normothermic Perfusion of Isolated Organs Market Size Market Share by Region (2021-2026)
Figure 19. Americas Normothermic Perfusion of Isolated Organs Market Size 2021-2026 ($ millions)
Figure 20. APAC Normothermic Perfusion of Isolated Organs Market Size 2021-2026 ($ millions)
Figure 21. Europe Normothermic Perfusion of Isolated Organs Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Normothermic Perfusion of Isolated Organs Market Size 2021-2026 ($ millions)
Figure 23. Americas Normothermic Perfusion of Isolated Organs Value Market Share by Country in 2025
Figure 24. United States Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Normothermic Perfusion of Isolated Organs Market Size Market Share by Region in 2025
Figure 29. APAC Normothermic Perfusion of Isolated Organs Market Size Market Share by Type (2021-2026)
Figure 30. APAC Normothermic Perfusion of Isolated Organs Market Size Market Share by Application (2021-2026)
Figure 31. China Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 35. India Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Normothermic Perfusion of Isolated Organs Market Size Market Share by Country in 2025
Figure 38. Europe Normothermic Perfusion of Isolated Organs Market Size Market Share by Type (2021-2026)
Figure 39. Europe Normothermic Perfusion of Isolated Organs Market Size Market Share by Application (2021-2026)
Figure 40. Germany Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 41. France Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Normothermic Perfusion of Isolated Organs Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Normothermic Perfusion of Isolated Organs Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Normothermic Perfusion of Isolated Organs Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Normothermic Perfusion of Isolated Organs Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 54. APAC Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 55. Europe Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 57. United States Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 58. Canada Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 59. Mexico Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 60. Brazil Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 61. China Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 62. Japan Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 63. Korea Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 65. India Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 66. Australia Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 67. Germany Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 68. France Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 69. UK Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 70. Italy Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 71. Russia Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 72. Egypt Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 73. South Africa Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 74. Israel Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 75. Turkey Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)
Figure 76. Global Normothermic Perfusion of Isolated Organs Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Normothermic Perfusion of Isolated Organs Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Normothermic Perfusion of Isolated Organs Market Size 2027-2032 ($ millions)